Pre-treatment calprotectin (MRP8/14) provides no added value to testing CRP alone in terms of predicting response to TNF inhibitors in rheumatoid arthritis in a post-hoc analysis

Samantha Smith, Sheree Alexander, Nisha Nair, Sebastien Viatte, Stephen Eyre, Kimme Hyrich, Ann W. Morgan, Anthony G. Wilson, John D. Isaacs, Biologics in Rheumatoid Arthritis Genetics and Genomics Study Syndicate (BRAGGSS), Darren Plant, Anne Barton

Research output: Contribution to journal › Article › peer-review

Fingerprint

Dive into the research topics of 'Pre-treatment calprotectin (MRP8/14) provides no added value to testing CRP alone in terms of predicting response to TNF inhibitors in rheumatoid arthritis in a post-hoc analysis'. Together they form a unique fingerprint.

Pharmacology, Toxicology and Pharmaceutical Science

Immunology and Microbiology

Biochemistry, Genetics and Molecular Biology